Geographical accessibility of medicines: a systematic literature review of pharmacy mapping

Abstract

Background Measuring access to medicines has often been limited to assessing availability and affordability, while little is known regarding other dimensions of access including geographical accessibility. Our study aims to provide a systematic review of literature on the accessibility of medicines by studying the geographical distribution of pharmacies using Spatial Analytical methods. Methods As systematic review of scientific peer-reviewed literature between 2000 and 2018 was carried out using PubMed, Web of Science, Google Scholar, Google and the Preferred Reporting items for Systematic Reviews and Meta-Analyses (PRISMA). Data regarding pharmacy density, distance to pharmacies in relation of pharmacy to sociodemographic factors and pharmacy characteristics were extracted from studies that meet the inclusion criteria. Findings Twenty papers fulfilled our inclusion criteria, of which only three were from middle income countries and rest from high-income economies. Pharmacy density per population was reported in 15 studies. Although geographical information was utilized in all studies, only 14 studies reported distance to pharmacies represented as Euclidean (straight line) distance. Disparities in accessibility was reported according to population income and rural or urban location. Seven studies described additional pharmacy characteristics including opening hours, presence of a pharmacist and delivery services. Conclusions Geographical accessibility is a key dimension of access to medicines. Pharmacy density per population is a relevant indicator to assess geographical accessibility which should be complemented by an equity analysis using socio-demographic information and population perception of accessibility.

Measuring COVID-19 vaccination coverage: an enhanced age-adjusted two-step floating catchment area model

“…The real distance, i.e. the accessibility dimension, must be calculated considering all possible road connections available [ 15 , 16 ], e.g., the drive time from an individual’s home to the healthcare centre [ 17 – 19 ]. As accessibility is related to geographical factors it is also labelled spatial access with affordability, accommodation and acceptability considered non-spatial access dimensions, while the availability dimension falls somewhere in-between [ 20 , 21 ].…”

Real-World Impact of Transferring the Dispensing of Hospital-Only Medicines to Community Pharmacies During the COVID-19 Pandemic

“… 18 , 19 , 20 Moreover, higher convenience of CP location is reflected in the travel mode preferred by respondents, with the majority reporting going on foot to CP versus by car to HP. Given that geographical accessibility is a key dimension of access to medicines, 21 the proximity of CP to subjects also seems to contribute to reduce absenteeism and traveling time, resulting in savings to patients and caregivers. Similar findings were found in a pilot study 22 previously conducted in Portugal and framed by the National Strategy for Medicines 2016 to 2020 that foresaw the valuation of CP as healthcare providers, including the possibility of HOM dispensing at that setting.…”

The role of integrated medical and prescription drug plans in addressing racial and ethnic disparities in medication adherence

“…Many lower-income and minority residents face "pharmacy deserts," loosely defined as geographic areas lacking access to a nearby pharmacy and where pharmacy services are scarce or difficult to obtain. 23,[46][47][48] Pharmacy deserts disproportionately exist in segregated Black communities, and this disparity has widened over time, 23 with documented impacts on medication adherence. 49…”